Somatostatin Receptor 2A (EP149) Rabbit Monoclonal Primary Antibody
Specialties: Anatomic Pathology Neuropathology
Somatostatin Receptor 2A (SSTR2A) is a protein highly expressed in pancreas binding somatostatin and inhibiting pancreatic enzyme secretion.1 SSTR2A is used as a marker for identifying meningioma from other spindle-cell tumors such as solitary fibrous tumor.2,3 SSTR2A is more frequently expressed in higher grade meningiomas and associated to its microvessel proliferation.4 SSTR2A has demonstrated utility as a diagnostic marker for follicular dendritic cell sarcomas and some other related tumors.5
- Kailey, Balrik et al. "SSTR2 is the functionally dominant somatostatin receptor in human pancreatic β- and a-cells." American journal of physiology. Endocrinology and metabolism vol. 303,9 (2012): E1107-16. doi:10.1152/ajpendo.00207.2012
- Menke, Joshua R et al. "Somatostatin receptor 2a is a more sensitive diagnostic marker of meningioma than epithelial membrane antigen." Acta neuropathologica vol. 130,3 (2015): 441-3. doi:10.1007/s00401-015-1459-3
- Boulagnon-Rombi, Camille et al. "Immunohistochemical Approach to the Differential Diagnosis of Meningiomas and Their Mimics." Journal of neuropathology and experimental neurology vol. 76,4 (2017): 289-298. doi:10.1093/jnen/nlx008
- Barresi, V et al. "Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?." Oncology reports vol. 20,3 (2008): 485-92.
- Tao, Li-Li et al. "SSTR2a Is a Useful Diagnostic Marker for Follicular Dendritic Cells and Their Related Tumors." The American journal of surgical pathology vol. 43,3 (2019): 374-381. doi:10.1097/PAS.0000000000001205
Specifications
- Reactivity: paraffin
- Control: Meningioma (Cytoplasmic, Membranous); Pancreas (Cytoplasmic, Membranous); Lymph node (Cytoplasmic, Membranous)
- Dilution Range: 1:25-1:100 *
Package Inserts
IFU
- IVD Rev. 0.0 (CMC48631000)
Have a different keycode?
Click Here
Learn how to obtain your SDS
Ordering Information
For in vitro diagnostic (IVD) use in USA
| 0.1 mL concentrate | 486R-14 |
| 0.5 mL concentrate | 486R-15 |
| 1.0 mL concentrate | 486R-16 |
| 1.0 mL predilute ready-to-use | 486R-17 |
| 7.0 mL predilute ready-to-use | 486R-18 |
For research use only (RUO) in Canada
| 0.1 mL concentrate (RUO) | 486R-14-RUO |
| 1.0 mL concentrate (RUO) | 486R-16-RUO |
| 1.0 mL predilute ready-to-use (RUO) | 486R-17-RUO |
| 7.0 mL predilute ready-to-use (RUO) | 486R-18-RUO |
For in vitro diagnostic (IVD) use in Europe
| 0.1 mL concentrate | 486R-14 |
| 0.5 mL concentrate | 486R-15 |
| 1.0 mL concentrate | 486R-16 |
| 1.0 mL predilute ready-to-use | 486R-17 |
| 7.0 mL predilute ready-to-use | 486R-18 |
For research use only (RUO) in Japan
| 0.1 mL concentrate (RUO) | 486R-14-RUO |
| 1.0 mL concentrate (RUO) | 486R-16-RUO |
| 1.0 mL predilute ready-to-use (RUO) | 486R-17-RUO |
| 7.0 mL predilute ready-to-use (RUO) | 486R-18-RUO |
To request information on this product in additional countries, please click the button below.